ACT Oncology is a full-service, oncology specialist, clinical research organization (CRO) providing expert, flexible and cost-effective support for our Biotech Sponsors’ North American and International development programs. Our dedicated team of experts is committed to optimizing oncology drug research and to bringing new treatments to the market quickly and efficiently.
ACT Oncology invites you to join us in Boston from 15-16 July, 2014 for the Third Annual Clinical Operations in Oncology Trials East Coast. As a Sponsor of this event, ACT Oncology’s President, Patricia Devitt, Pharm.D., will be a featured Speaker. Please contact our Business Development Team to arrange a meeting: Chris Ellis: 917-940-6464 and Pat Terek: 650-868-1788
ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 23 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.